BTREX PLUS, Dietary Supplement 2 caplets bottles, UPC 05380930802 (Physician Samples)
Published June 23, 2021 · Recall initiated: May 25, 2021
Summary
FDA records food Class III recall F-0666-2021, published June 23, 2021 and initiated May 25, 2021. Recalling firm: Lopez Gonzalez Santana Corporation; Status: Terminated; Reported quantity: 4641 units (2 tablet bottles); Lot: Lot #30637, Expiration Date 01. 2022. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Presence of damaged tablets
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Lopez Gonzalez Santana Corporation
- Distributor
- Domestic distribution only-PR
- Lot
- Lot #30637, Expiration Date 01. 2022
- Risk classification
- Class III
- Area (FDA)
- food
- Country
- United States
Related recalls
- FDABTREX PLUS, Dietary Supplement 100 Caplets, UPC 05380930801June 23, 2021
- FDAOlde Thompson Organic Ground Coriander 1.5oz. in glass jar with flip-top lid. Sun Harvest Organic CorianderJune 23, 2021
- FDAKetamine HCl Injection Solution, 10 mg / 2 mL (5 mg/mL), Rx Only, Compounded by Prisma Health OutsourcingJune 23, 2021
- FDABTREX PLUS, Dietary Supplement 2 Caplets, UPC 05380930802 (Physician Samples)May 26, 2021
- FDABTREX PLUS, Dietary Supplement 100 CapletsMay 26, 2021
- FDABTREX PLUS, Dietary Supplement 100 CapletsMay 19, 2021
Questions about this recall
Was BTREX PLUS, Dietary Supplement 2 caplets bottles, UPC 05380930802 (Physician Samples) recalled?
Yes. FDA published recall F-0666-2021 on June 23, 2021. Reported hazard: CGMP Deviations: Presence of damaged tablets
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit